The Drug Enforcement Administration’s plan to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act is expected to impact many aspects of the cannabis industry, such as advertising, taxes, research, and shipping. However its impact on the cannabis real estate sector could be particularly pronounced.